Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
CFCS is genetically heterogeneous and mutations in the KRAS, BRAF, MAP2K1 (MEK1) and MAP2K2 (MEK2) genes, encoding for components of the RAS-mitogen activated protein kinase (MAPK) signaling pathway, have been identified in up to 90% of cases.
|
19156172 |
2009 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Cardiofaciocutaneous Syndrome (CFCS) is a rare genetic syndrome caused by mutations in one of four genes: BRAF, MAP2K1, MAP2K2, and KRAS.
|
26842671 |
2016 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Cardiofaciocutaneous syndrome (CFCS) is a rare developmental disorder that is phenotypically similar to Noonan syndrome and is associated with mutations in BRAF, MEK1, MEK2, and KRAS.
|
31125963 |
2019 |
Cardio-facio-cutaneous syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Biochemical and functional characterization of germ line KRAS mutations.
|
17875937 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Biochemical and functional characterization of germ line KRAS mutations.
|
17875937 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
|
17704260 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.
|
17704260 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
Biomarker
|
disease |
CTD_human |
Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency.
|
17703371 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Congenital ulcerating hemangioma in a baby with KRAS mutation and cardio-facio-cutaneous syndrome.
|
17551339 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations.
|
19396835 |
2009 |
Cardio-facio-cutaneous syndrome
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Craniosynostosis in patients with Noonan syndrome caused by germline KRAS mutations.
|
19396835 |
2009 |
Cardio-facio-cutaneous syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features.
|
17601930 |
2007 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes.
|
23059812 |
2013 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction.
|
8246952 |
1993 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genetic analysis revealed individual heterozygous mutations in the KRAS (phenotype of CFC/Noonan syndrome) and BRAF genes (phenotype of CFC syndrome).
|
21871821 |
2012 |
Cardio-facio-cutaneous syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Genetic analysis revealed individual heterozygous mutations in the KRAS (phenotype of CFC/Noonan syndrome) and BRAF genes (phenotype of CFC syndrome).
|
21871821 |
2012 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
Biomarker
|
disease |
CLINGEN |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome.
|
16474404 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Germline KRAS mutations were shown recently to be associated with developmental disorders, including Noonan syndrome (NS), cardio-facio-cutaneous syndrome (CFCS), and Costello syndrome (CS).
|
20949621 |
2011 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Germline KRAS mutations cause Noonan syndrome.
|
16474405 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Germline KRAS mutations cause Noonan syndrome.
|
16474405 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype.
|
16773572 |
2006 |
Cardio-facio-cutaneous syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Germline mutations in KRAS have recently been identified in a small number of patients with Noonan syndrome and CFC.
|
17056636 |
2007 |